Medindia

X

Despite FDA Recommendation for Postmarketing Surveillance, Amgen's Prolia Will Achieve Blockbuster Sales for Treatment of Osteoporosis

Friday, January 8, 2010 Medical PDA News J E 4
Advertisement
Prolia's Uptake Will Likely be Tempered Until Long-Term Safety is Verified, According to New Findings from Decision Resources

Decision Resources

Decision Resources, Inc.

Christopher Comfort

Elizabeth Marshall

781-296-2597

781-296-2563

ccomfort@dresources.com

emarshall@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
UnitedHealth Finds Success in Las Vegas With Sierr...
S
A Hypertension Drug Requiring Less-Frequent Dosing...